Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19

PURPOSE OF REVIEW: To summarise the current understanding of post-infectious olfactory dysfunction (PIOD) and provide a consensus on management of the condition through an evidence-based approach, critically reviewing the available management options. RECENT FINDINGS: New studies investigating the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Sohaib, Ash, Javier, Addison, Alfred, Philpott, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
RHINOLOGY: Taste and Smell Disorders (C Philpott, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579639/
https://www.ncbi.nlm.nih.gov/pubmed/36276576
http://dx.doi.org/10.1007/s40136-022-00435-0
Descripción
Sumario:PURPOSE OF REVIEW: To summarise the current understanding of post-infectious olfactory dysfunction (PIOD) and provide a consensus on management of the condition through an evidence-based approach, critically reviewing the available management options. RECENT FINDINGS: New studies investigating the pathophysiology of PIOD in COVID-19 patients have found that in those with persistent symptoms there is an association with lower tissue perfusion in the orbital and medial regions of the frontal lobe. Recent meta-analyses have listed olfactory training as the first line management for PIOD. SUMMARY: Olfactory training remains the most recommended management option for PIOD. The use of systemic corticosteroids to treat PIOD is not encouraged due to poor evidence.

Ejemplares similares